卵巢癌患者的衰弱及医疗可及性、种族和民族的作用
基于SEER-Medicare数据库纳入2009至2015年确诊、年龄≥65岁的6041例卵巢癌患者,分析医疗可及性与种族/民族和诊断前后衰弱的关联。诊断后衰弱患病率升至58.8%,非西班牙裔黑人和西班牙裔患者更高;
要点
- 诊断前14.7%患者衰弱,诊断后衰弱患病率升至58.8%。
- 诊断后衰弱患病率非西班牙裔白人58.2%、非西班牙裔黑人65.2%、西班牙裔70.2%。
核心结论
- 卵巢癌患者诊断后衰弱患病率高,非西班牙裔黑人和西班牙裔患者尤其明显。
- 改善医疗可负担性可能预防或帮助管理Medicare患者的衰弱、改善癌症治疗接受度和提高癌症生存。
研究设计与样本
- 使用SEER-Medicare数据库识别2009至2015年确诊、年龄≥65岁的西班牙裔、非西班牙裔黑人和非西班牙裔白人卵巢癌患者,共纳入6041例。
- 采用对数二项回归估计医疗可及性和种族/民族与诊断前或诊断后衰弱的患病比(PR)及95%置信区间(CI),校正年龄和合并症。
主要发现
- 纳入患者中非西班牙裔白人占91.8%、非西班牙裔黑人占6.6%、西班牙裔占1.7%。
- 诊断前14.7%患者被定义为衰弱(非西班牙裔白人14.3%、非西班牙裔黑人17.9%、西班牙裔20.8%)。
- 诊断后衰弱患病率增至58.8%(非西班牙裔白人58.2%、非西班牙裔黑人65.2%、西班牙裔70.2%)。
- 完全校正模型中,种族/民族与诊断前或诊断后衰弱均无统计学显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Ovarian cancer has poor 5-year survival, particularly among non-Hispanic (NH) Black patients. Efforts to identify patients at high-risk of functional limitations and frailty may improve outcomes. In this study, we examined how healthcare access (HCA) and race/ethnicity relate to frailty among patients with ovarian cancer. METHODS: We identified Hispanic, NH Black, and NH White patients diagnosed at ages ≥6 5 years with ovarian cancer between 2009 and 2015 using SEER-Medicare. Log-binomial regression was used to estimate prevalence ratios (PRs) and 95% confidence intervals (CIs) for the association between HCA and race/ethnicity with pre- or post-diagnosis frailty, adjusting for age and comorbidities. RESULTS: A total of 6041 patients with ovarian cancer were included, including 91.8% NH White, 6.6% NH Black, and 1.7% Hispanic. Pre-diagnosis, 14.7% of patients were defined as frail (NH White: 14.3%; NH Black: 17.9%; Hispanic: 20.8%). Post-diagnosis, frailty prevalence increased to 58.8% (NH White: 58.2%; NH Black: 65.2%; Hispanic: 70.2%). No statistically significant associations were observed between race/ethnicity and pre- or post-diagnosis frailty in fully adjusted models. After adjustment for patient characteristics and healthcare accessibility and availability, higher healthcare affordability was associated with a decreased prevalence of pre-diagnosis frailty (PR: 0.91, 95% CI: 0.8 5, 0.98). CONCLUSIONS: Patients with ovarian cancer have a high prevalence of frailty after diagnosis, particularly NH Black and Hispanic patients. Improving healthcare affordability may prevent or help manage frailty in Medicare patients, improve receipt of cancer treatment, and increase cancer survival.
引用
- Meernik C, Osazuwa-Peters OL, Wilson LE, et al. Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity. Gynecol Oncol. 2024. PMID: 39213779. doi:10.1016/j.ygyno.2024.08.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。